MedCity and London & Partners launch Genomics campaign
Posted on
MedCity and London & Partners has launched its Genomics campaign, focussing on the pioneers from the Golden Triangle of Cambridge, London and Oxford, working in the sector, that are making their mark in healthcare and precision medicine through a combination of technology and science. Find out about the industry, academia and government organisations in the genomics sector and the role the Golden Triangle is playing in the future of healthcare. Read the report.
“In driving the 100K Genome Project we are helping to create an invaluable national asset. In combining genomic and clinical data we are delivering a unique proposition – only possible using a comprehensive, diverse healthcare system such as the NHS.”
Joanne Hackett, Chief Commercial Officer, Genomics England
Related content
DigitalHealth.London Spotlight: CyberLiver
Every week, we shine a spotlight on one of our DigitalHealth.London companies, founders, or NHS fellows. Today, to commemorate World Liver Day, we are excited to feature our current DigitalHealth.London Accelerator company CyberLiver.
Bridging Gaps in Women’s Health: The Rise of FemTech Innovation
As innovations in FemTech continue to evolve, the future of women’s health holds promise for improved equity and accessibility. In this blog, Lavinia Pamparau, NHS Navigator for DigitalHealth.London, delves into how FemTech solutions tackle prevailing health disparities and empower women to proactively manage their health and well-being.
Getting FemTech into the NHS
FemTech has the potential to tackle health inequalities related to gender and improve the quality of life for millions of women in the UK. But, to achieve maximum impact, FemTech needs to be fully integrated into NHS pathways and services. In this blog, NHS Navigator for DigitalHealth.London Yasmin Stinchcombe explores how FemTech innovators can successfully engage with the NHS.
